Topics:

Hoechst Marion Roussel Launches Antiemetic Information Center

Hoechst Marion Roussel Launches Antiemetic Information Center

Two of the most distressing side effects of cancer treatment, nausea and vomiting, cause enough fear in some patients to induce them to delay or abandon potentially curative treatment. Some studies of surgical patients suggest that the fear of nausea and vomiting is even greater than the fear of postoperative pain.

To help health care professionals provide care for these patients, Hoechst Marion Roussel, launched the Anzemet (dolasetron mesylate injection/tablets) Information Center at www.anzemet.com.

The web site provides:

Information on the prevention of chemotherapy-induced nausea and vomiting and the prevention and treatment of postoperative nausea and vomiting;

Access to dolasetron product information, including information on the pharmacology, efficacy, safety, and administration of dolasetron;

Data on the pharmacology, efficacy, safety, and administration of dolasetron;

Information about the Anzemet Reimbursement and Patient Assistance programs

Educational resources for cancer patients

Hoechst Marion Roussel also developed two patient education pamphlets that can be accessed in the Professional Resources area of the site. "Working Your Way Through Chemotherapy: Advice From A Good Friend" addresses the specific issues of cancer patients who continue to work while undergoing chemotherapy. "Speaking From Experience: Insights From Cancer Survivors and Their Families" informs patients and families about what chemotherapy is like and how to get and give help during chemotherapy.

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.